AngioDynamics (NASDAQ: ANGO) stock soared 10.5% through 11:25 a.m. ET Thursday after beating on "earnings" (sort of) this morning.

Heading into the report, analysts forecast AngioDynamics would lose $0.12 per share in its fiscal Q1 2026, on sales of $72.7 million. In fact, the medical devices maker lost only $0.10 per share (technically a "beat," but still a loss), and sales were 75.7 million.

Image source: Getty Images.

Continue reading

Source Fool.com